Guardian Australia · US healthcare

US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises

· By Eric Berger
Story summary

Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity

Read at Guardian Australia

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.